The Porcine epidemic diarrhea virus (PEDV) is a coronavirus that causes severe diarrhoea and a high mortality rate in suckling piglets. Traditional antiviral measures such as vaccinations have not shown sufficient effectiveness in protecting piglets against PEDV infection. Given its important role in viral polyprotein processing, the PEDV 3C-like proteinase (3CL pro ) may be a potential target for the development of antiviral drugs adopting a structure-guided approach. To facilitate these efforts, we have expressed, purified, and successfully crystallized a recombinant PEDV 3CL
The Porcine epidemic diarrhea virus (PEDV) is a coronavirus that causes severe diarrhoea and a high mortality rate in suckling piglets. Traditional antiviral measures such as vaccinations have not shown sufficient effectiveness in protecting piglets against PEDV infection. Given its important role in viral polyprotein processing, the PEDV 3C-like proteinase (3CL pro ) may be a potential target for the development of antiviral drugs adopting a structure-guided approach. To facilitate these efforts, we have expressed, purified, and successfully crystallized a recombinant PEDV 3CL
pro that presents the cognate N-and C-termini of the viral protein. In addition, we have developed an in vitro enzymatic activity assay for screening anti-PEDV 3CL pro inhibitors using FRET-based peptide substrates. We are currently working to solve the 3-dimenstional structures of PEDV 3CL pro in complex with various substrate analogues and inhibitors. The structural information garnered through these studies will help shed light on the mechanisms of catalysis and inhibition as well as possible chemical modifications of the inhibitors that may improve their specificity and potency.
